Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Avantor, Inc. (AVTR) Guidance & Earnings Results

On 2026-07-29 Avantor, Inc. raised guidance: "FY2026 organic revenue growth raised to -0.5% to +0.5% from -2.5% to -0.5%; adjusted EPS raised to $0.80-$0.83 from $0.77-$0.83; adjusted EBITDA margin unchanged 14.8%-15.3%; free cash flow unchanged…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AVTRAvantor, Inc.Follow AVTR — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
11.7B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
28 Oct, in 4 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
29 Jul 26RaisedFY2026 organic revenue growth raised to -0.5% to +0.5% from -2.5% to -0.5%; adjusted EPS raised to $0.80-$0.83 from $0.77-$0.83; adjusted EBITDA margin unchanged 14.8%-15.3%; free cash flow unchanged $500M-$550M · full year
29 Apr 26ReaffirmedReaffirms FY 2026 guidance · full year

Avantor, Inc. — questions

What guidance did Avantor, Inc. give?
On 2026-07-29: "FY2026 organic revenue growth raised to -0.5% to +0.5% from -2.5% to -0.5%; adjusted EPS raised to $0.80-$0.83 from $0.77-$0.83; adjusted EBITDA margin unchanged 14.8%-15.3%; free cash flow unchanged $500M-$550M"
When does Avantor, Inc. report earnings?
Avantor, Inc.'s next earnings report is expected on 2026-10-28.

Every figure on this page comes from Avantor, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.